Hypertension is associated with worse cognitive function and hippocampal hypometabolism in Alzheimer's disease

Adiposity, Type 2 Diabetes, and Alzheimer's Disease

(2017) José A. Luchsinger et al.   JOURNAL OF ALZHEIMERS DISEASE

Brain fluorodeoxyglucose (FDG) PET in dementia

(2016) Takashi Kato et al.   AGEING RESEARCH REVIEWS

Decreased hippocampal metabolism in high-amyloid mild cognitive impairment

(2016) Bernard J. Hanseeuw et al.   Alzheimers & Dementia

Risk Factors Associated With Cognitive, Functional, and Behavioral Trajectories of Newly Diagnosed Dementia Patients

(2016) Eric Jutkowitz et al.   JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES

Chronic cerebral hypoperfusion enhances Tau hyperphosphorylation and reduces autophagy in Alzheimer’s disease mice

(2016) Lifeng Qiu et al.   Scientific Reports

Clinical trial of an inhibitor of RAGE-A  interactions in Alzheimer disease

(2014) D. Galasko et al.   NEUROLOGY

Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease

(2014) Stephen Salloway et al.   NEW ENGLAND JOURNAL OF MEDICINE

Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease

(2014) Rachelle S. Doody et al.   NEW ENGLAND JOURNAL OF MEDICINE

Hypertension

(2013) Giuseppe Faraco et al.   HYPERTENSION

Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy

(2013) Chia-Chen Liu et al.   Nature Reviews Neurology

A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease

(2013) Rachelle S. Doody et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety and Tolerability of the γ-Secretase Inhibitor Avagacestat in a Phase 2 Study of Mild to Moderate Alzheimer Disease

(2012) Vladimir Coric et al.   ARCHIVES OF NEUROLOGY

Gesture comprehension, knowledge and production in Alzheimer’s disease

(2012) M. Rousseaux et al.   EUROPEAN JOURNAL OF NEUROLOGY

Does vascular pathology contribute to Alzheimer changes?

(2012) Raj N. Kalaria et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Revision of the criteria for Alzheimer's disease: A symposium

(2011) Steven T. DeKosky et al.   Alzheimers & Dementia

The projected effect of risk factor reduction on Alzheimer's disease prevalence

(2011) Deborah E Barnes et al.   LANCET NEUROLOGY

The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics

(2011) Eric Karran et al.   NATURE REVIEWS DRUG DISCOVERY

A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease

(2011) S. Salloway et al.   NEUROLOGY

Diabetes, Alzheimer disease, and vascular dementia: A population-based neuropathologic study

(2010) S. Ahtiluoto et al.   NEUROLOGY

Microvasculature changes and cerebral amyloid angiopathy in Alzheimer’s disease and their potential impact on therapy

(2009) Roy O. Weller et al.   ACTA NEUROPATHOLOGICA

A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking

(2009) C. E. Teunissen et al.   NEUROLOGY

Vascular factors and risk for neuropsychiatric symptoms in Alzheimer's disease: the Cache County Study

(2008) Katherine A. Treiber et al.   INTERNATIONAL PSYCHOGERIATRICS

High Blood Pressure, Hypertension, and High Pulse Pressure Are Associated with Poorer Cognitive Function in Persons Aged 60 and Older: The Third National Health and Nutrition Examination Survey

(2008) Thomas Olabode Obisesan et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Recall and recognition of verbal paired associates in early Alzheimer's disease

(2008) G.J. LOWNDES et al.   JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY